Application Information

This drug has been submitted to the FDA under the reference 012928/002.

Names and composition

"NOVRAD" is the commercial name of a drug composed of LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
012928/002 NOVRAD LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS SUSPENSION/ORAL EQ 50MG BASE per 5ML
012928/004 NOVRAD LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS CAPSULE/ORAL EQ 100MG BASE
012928/006 NOVRAD LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS CAPSULE/ORAL EQ 50MG BASE

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
012928/002 NOVRAD LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS SUSPENSION/ORAL EQ 50MG BASE per 5ML
012928/004 NOVRAD LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS CAPSULE/ORAL EQ 100MG BASE
012928/006 NOVRAD LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS CAPSULE/ORAL EQ 50MG BASE

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved